Providing innovative and flexible ways to study B-cell phenotypes and functions.
For more than two decades researchers have made significant discoveries about B-cell biology and phenotypes using BD Biosciences flow cytometry products, including instruments, reagents, and protocols.
BD continues to support researchers by introducing innovative tools to study multiple aspects of B-cell biology. Newly defined, key markers include the transcription factors Blimp-1 and XPB-1s, which allow analysis of these key regulators in different B-cell subsets. To support and simplify the detection of these critical intracellular molecules in B cells by flow cytometry, we offer antibodies validated for flow cytometry, as well as optimized buffer systems for staining.
B cells pass through a number of developmental stages both before and after exposure to antigens. As they mature and differentiate, they give rise to multiple functionally distinct subsets.
Differential expression of cell surface and intracellular markers, as well as their distinct immunoglobulin and cytokine secretion profiles, provide valuable clues to the diverse nature and function of the different B-cell subsets.
For example, the expression of syndecan-1 (CD138) distinguishes circulating plasmablasts and plasma cells, the “professional” antibody-secreting B cells, from other developmental and functional subsets.
To support the use of multicolor flow cytometry for the study of B cells, BD offers a wide portfolio of reagents for B-cell phenotyping. They are available in multiple formats, to provide maximum flexibility in panel design. We continue to add new specificities as new markers emerge.
The schematic summarizes the main developmental and differentiation stages, as well as some of the key markers associated with each B-cell subset in mouse and human.
Conventional B-Cell Maturation
B cells originate from hematopoietic stem cells (HSCs) located in bone marrow, where they pass through the first stages of development. The still immature B cells then migrate to secondary lymphoid tissues, where most of them continue their development into mature follicular B cells. 1 When the B-cell receptor (BCR) complex of a mature B cell, consisting of the membrane-bound (m) forms of IgM and IgD, binds its cognate foreign antigen, the cell becomes activated and differentiates into an antibody-secreting plasma cell. 2
B-Cell Subsets with Different Functions
B cells also follow alternative differentiation pathways from those of conventional B cells, resulting in subsets that have distinct functions and marker expression patterns. For example, marginal-zone (MZ) B cells function as innatelike cells. Unlike conventional B cells, they can be activated through Toll-like receptor (TLR)-ligation, bypassing the BCR. They also tend to express CD1d and CD21, but not CD23. 1,2 B-cell subsets with regulatory function have been identified and are distinguished by their ability to secrete IL-10 or TGF-β-1. 1–4
Analysis of B-Cell Maturation
With a comprehensive selection of antibodies to mouse and human markers, BD can support a wide variety of phenotyping panels for the study of B cells across all developmental stages.
To illustrate the use of differential marker expression for B-cell analysis, seven cell surface markers were used to analyze B-cell subsets in mouse bone marrow, allowing discrimination of seven different developmental phases in this tissue.
Pre-pro-B, Pro-B, and Pre-B cells could be distinguished within the low positive CD45R/B220 population based on their differential expression of BP1 and CD24. Immature, transitional, and early and late mature B cells could be segregated based on differential expression of IgM and IgD. The expression of the IL-7 receptor, CD127, was analyzed in these different subsets, and was shown to decrease as B cells matured.
1. Allman D, Pillai S. Peripheral B cell subsets. Curr Opin Immunol. 2008;20:149-157.
2. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nature Rev Immunol. 2005;5:230-242.
3. Lund FE. Cytokine-producing B lymphocytes–key regulators of immunity. Curr Opin Immunol. 2008;20:332-338.
4. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221-241.
A multicolor immunophenotyping approach is well suited to the study of B cells, since B cells by nature require the use of more markers than, for example, T cells, to define the basic subsets present in most samples.
A wide variety of B-cell studies employs cell surface markers that define the major B-cell subsets, and these form the "backbone," or core, for panels to do more detailed analysis.
The key marker for B-cell panels is the lineage marker CD19, which is expressed by almost all cells belonging to the B-cell lineage. In the mouse, CD45R/B220 is traditionally used. Most panels also include surface-expressed IgD and IgM, since the BCR isotype provides information about the differentiation stage of the B cells.
To provide flexibility in panel design, BD offers all of these markers in a wide selection of formats.
Depending on the type of sample that is being analyzed, different markers can be selected to define the specific B-cell subsets of interest. The example shown analyzes human peripheral blood using CD19, CD20, IgD, CD27, CD38, and CD24. With this six-color panel it is possible to identify transitional B cells (CD24high, CD38high), to discriminate between naïve and memory cells (naïve cells are CD27–IgD+, memory cells CD27+IgD–), and identify plasmablasts (CD38+).1
Because the phenotype of some subsets is very similar to others, often a more extensive phenotyping panel is required. For example, a panel might distinguish the many B-cell developmental stages present in bone marrow B cells.
Adding markers can also provide a more fine-detail analysis, for example, defining memory cells or different types of plasma cells. Other molecules offer insight into the potential for cells to home and localize within the body (chemokine receptors, CD62L). Adding activation markers (CD69, CD25, CD80, CD86) can inform about which subsets are activated, and provide important clues about an individual's immune response.
Tools for Building Panels
Antigen Density. When adding markers to a panel, researchers can take advantage of antigen-density information to optimize antigen-fluor selection. In general, we recommend choosing bright fluorochromes for markers with low antigen density, and the less bright fluorochromes for highly expressed markers. To support researchers, BD is generating information about the antigen density of a number of markers on peripheral blood cells.
Bright Conjugates for Dim Markers. Certain B-cell populations are so rare, or defined by dimly expressed antigens, that achieving sufficient resolution is critical to obtaining good data in staining experiments. In particular for such rare or dim populations, the use of very bright fluorochromes helps improve resolution. A number of B-cell marker antibodies are available conjugated to very bright BD Horizon™ Brilliant Violet™ (BV) dyes, such as BD Horizon™ Brilliant Violet™ 421 (BV421), BD Horizon™ Brilliant Violet™ 510 (BV510), and BD Horizon™ Brilliant Violet™ 605 (BV605).
An Extended Panel for Defining Additional Subsets
In designing the panel used for the 10-color analysis experiment shown, information about antigen density helped optimize the fluorochrome distribution. Bright fluorochromes were chosen for the low-density antigen CD138 and to allow resolution of populations expressing different levels of IgD and CD38, and the extremely bright BV dyes were used to obtain optimal detection of CD27 and IgM.
Analysis using this panel provided the additional information about Ig subclass expression, allowing identification of both IgG+ and IgG– post-class-switched memory cells (IgM–IgD–CD38–CD27+/dim), and the clear discrimination of plasma cells (IgM–IgD–CD20–CD38m++).
1. Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nature Rev Immunol. 2012;12:191-200.
Measurement of the types and amounts of immunoglobulins and cytokines that are secreted by B cells provides insight into the quality and quantity of their immune response—features that are also frequently altered in disease states.
Methods that allow multiplexed measurements are increasingly being used to measure immunoglobulins (Igs) and cytokines. In addition to the benefits of multiplex analysis, they have several unique advantages compared to classically used techniques.
BD Cytometric Bead Array: Multiplexed Quantitation
BD™ Cytometric Bead Array (CBA) is a bead-based immunoassay that can simultaneously quantify multiple analytes from the same sample. The BD CBA system uses antibody-coated beads to efficiently capture analytes, and flow cytometry for read-out.
The broad dynamic range of fluorescence detection, and multiplexed measurement, allow for small sample volume, fewer sample dilutions, and substantially less time to establish the value of an unknown, versus a conventional ELISA approach.
The BD CBA portfolio includes assays for measurement of a variety of soluble and intracellular proteins, including immunoglobulins and cytokines.
Visit our CBA Microsite for more information.
Table 1. Cytokine-producing B cells
|Cell type||Cytokines Secreted|
|B effector 1 (Be-1)||IFN-γ, IL-12, TNF|
|B effector 2 (Be-2)||IL-2, IL-4, IL-6, TNF|
|Regulatory B||IL-10, TGF-β1|
BD CBA Assays for Igs
The BD™ CBA Human Immunoglobulin Flex Set system provides ready-to-use reagents that serve as building blocks for the multiplexed quantitation of multiple Ig subclasses. Because the amount and type of antibody in a particular immune response can vary greatly, measurements of these parameters can provide insight into the response after immunization or vaccination, or serve as an indicator to assess immunoglobulin deficiency disorders. For example, BD CBA assays have been used to analyze the Igs and cytokines secreted by isolated B cells from HIV-infected individuals after CpG stimulation.1
BD CBA Assays for Cytokines
BD™ CBA Flex Sets for cytokines provide an open and configurable menu of bead-based reagents designed for easy and efficient multiplexing. The specificities include a wide range of human and mouse cytokines. Data comparing results using BD CBA Standards to the NIBSC/ WHO International Standards is available as a guideline, to facilitate comparisons of cytokine concentration values determined by different laboratories or methods.
Measuring which cytokines are secreted can also provide information about the activity of different functional B-cell subsets in a sample, such as B effector-1 or -2, or regulatory B cells (Bregs) secreting anti-inflammatory cytokines such as IL-10. 2 BD CBA Flex Sets have been used to quantitate the secretion of several B-cell–related cytokines and chemokines after manipulation of exhausted tissue-like B-memory cells in HIV-infected individuals. 3
1. Malaspina A, Moir S, DiPoto AC, et al. CpG oligonucleotides enhance proliferative and effector responses of B cells in HIV infected individuals. J Immunol. 2008;181:1199-1206.
2. Lund FE. Cytokine-producing B lymphocytes–key regulators of immunity. Curr Opin Immunol. 2008;20:332-338.
3. Kardava L, Moir S, Wang W, et al. Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J Clin Invest. 2011;121:2614-2624.
The development, activation, and differentiation of B cells are accompanied by a number of changes in intracellular molecules, including transcription factors, phosphosignaling proteins, and cytokines.
BD offers solutions that uniquely enable analysis of these intracellular molecules, to support researchers in deciphering the interconnected pathways regulating B-cell biology.
Basic principles of intracellular staining
Cells are fixed and permeabilized (symbolized by dashed line membrane), stained, and then analyzed by flow cytometry. For studies of secreted proteins, cells are first treated with a protein transport inhibitor to allow accumulation of the target protein inside the cell.
Multicolor flow cytometry is a powerful technique for the analysis of intracellular molecules. Simultaneous analysis with markers for specific cell subsets can reveal information about the differentiation and activation state of distinct populations of B cells. While techniques for cell surface staining are relatively standard, optimal staining for intracellular markers often depends on the biology of the target protein.
Specialized Buffers and Antibodies
To facilitate the detection of these intracellular molecules by flow cytometry, BD has developed monoclonal antibodies, specialized buffer systems, and kits that are optimized for detection of specific types of intracellular targets. Flow cytometry has several advantages over commonly used methods such as Western blot: multiple parameters can be measured simultaneously from heterogeneous samples such as blood. This conserves precious samples and provides detailed results at the cellular level.
Detection of Transcription Factors
The BD Pharmingen™ transcription factor buffer permeabilizes the cells sufficiently to allow the exposure of intranuclear epitopes, while still being gentle enough to allow the detection of most cell surface proteins. It can be used alone or in combination with cell surface markers and cytokines for an improved detection of a number of different transcription factors.
BD offers several B-cell–relevant, flow-validated transcription factor antibodies, including unique specificities. Some, such as Oct-2 and Pax-5, are expressed through the follicular or germinal center (GC) stages. Bcl-6 characterizes proliferating GC B cells, while others, such as Blimp-1 and XPB-1s, are typical for plasma cells.
Detection of Phosphoproteins
BD Phosflow™ antibodies are monoclonal phosphoepitope– specific antibodies validated for flow cytometric detection. The recommended permeabilization buffer for most BD Phosflow antibodies is BD Phosflow™ perm buffer III, but alternative permeabilization buffers also are available to meet particular experimental needs.
A number of BD Phosflow antibody specificities are available for analysis of signaling pathways involved in B-cell development and activation, including phospho-Akt, phospho-Btk, phospho-Syk, phospho-BLNK, phospho-CD20/ BL-CAM, phospho-IKKγ, phospho-NFκB, and phospho-mTOR.
Detection of Cytokines
Using a protein transport inhibitor to block secretion, researchers can detect cytokines in the cell in which they are being produced. This makes it possible to easily determine if the cytokine production by an activated cell population is the result of a few cells producing large amounts of cytokine or a large population of cells producing small quantities of cytokine per cell.
BD’s well established kits, buffer systems, and protocols for intracellular cytokine staining include BD Cytofix/ Cytoperm™ fixation/permeabilization solution, which is suitable for staining most cytokines and cell surface markers. A wide selection of direct conjugates is available, covering cytokines often used to distinguish Bregs, and those secreted by Be-1 and Be-2 cells.
Instrument setup for multicolor experiments using antibody panels of more than four colors can be time consuming.
When a panel of five markers is measured on two lasers, the fluorochromes that are typically used exhibit spillover into other fluorescence channels, thus requiring compensation. Researchers who have access to an instrument with four or five lasers can use this capability to their advantage, to simplify setup and minimize the need for compensation.
Five-laser instruments are often equipped with a 355-nm UV laser, which is typically used for side population analysis, calcium measurement using indo-1, or viability staining. To allow users to take full advantage of this equipment for phenotyping experiments, BD has developed a new UV-excited polymer-based dye, BD Horizon™ Brilliant Ultraviolet™ 395 (BUV395). Incorporating antibodies conjugated to BUV395 into a panel in which each fluorochrome is excited by a different laser results in minimal or no spillover between them.
This is illustrated by an example of a 5-color panel discriminating naive and memory B cells. Using this panel, only minimal setup and virtually no compensation were needed.
Combining Measurements to Maximize Results
Advances in buffer systems and methodologies now make it easier to simultaneously measure both surface and intracellular markers, and help researchers move toward information-rich, combined measurements. For example, several cell types in a heterogeneous sample of differentiating B cells can be monitored using a combination of cell surface and intracellular markers, to efficiently get more relevant data out of each sample.
The availability of antibodies to both B-cell surface markers and specific transcription factors in many different conjugates, including new BD Horizon™ dyes, adds flexibility when designing multicolor experiments.
Monitoring Pax-5 in Splenic B-cell Subpopulations
In the example shown, nine cell surface markers were used to analyze B-cell subsets in mouse spleen. They allowed discrimination between the different developmental phases present in this tissue. Follicular B I and II and marginal cell subsets (Marginal Zone and Marginal Zone Progenitor) were identified based on expression of IgM, IgD, CD21, and CD23. The different levels of IgM and CD23 expression helped distinguish the stages of transitional subsets (T1, T2, and T3).
Measurement of the expression of Pax-5 in the different subsets revealed differential Pax-5 expression in follicular and marginal zone B cells.
Product Information Sheets
- Bcl-6: An important transcription factor for B and T follicular helper (Tfh) cell differentiation)
- Human BD Fc Block™
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
FCAP Array is a trademark of Soft Flow Hungary Ltd.
APC-Cy7: US Patent 5,714,386
Alexa Fluor® is a registered trademark of Life Technologies Corporation.
Cy™ is a trademark of GE Healthcare. Cy™ dyes are subject to proprietary rights of GE Healthcare and Carnegie Mellon University, and are made and sold under license from GE Healthcare only for research and in vitro diagnostic use. Any other use requires a commercial sublicense from GE Healthcare, 800 Centennial Avenue, Piscataway, NJ 08855-1327, USA.
CF is a trademark of Biotium, Inc.